Evidence map›Paper›PMID 41384012›Full record

ArticleBiomaterials research2025

Erratum to "Nanotherapeutic System with Effective Microwave Sensitization and Pyroptosis Programming Enable Synergistic Microwave-Immunotherapy in Bladder Cancer".

Hao Deng, Jinliang Huang, Ning Gao, Zhi Liu, Zhenglin Yi, Jiatong Xiao, Xin Gao, Chunyu Zhang, Matsika Juliet, Jiao Hu and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomaterials research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Hao DengDepartment of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jinliang HuangDepartment of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Ning GaoDepartment of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Zhi LiuDepartment of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Zhenglin YiDepartment of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jiatong XiaoDepartment of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Xin GaoDepartment of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Chunyu ZhangDepartment of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Matsika JulietDepartment of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jiao HuDepartment of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jinbo ChenDepartment of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China.ORCID https://orcid.org/0009-0009-2049-6342
Xiongbing ZuDepartment of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.34133/bmr.0077.].

Identifiers

PMID41384012
PMCPMC12695094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.